26th IFPMA assembly – panel discussion III
Geneva, October 31, 2012
Panel III: “Societal Partner: Ensuring Innovation Serves Social and Business Needs”
Seth Berkley, CEO, GAVI Alliance
Caroline Roan, President, Pfizer Foundation
Mark Kramer, Co-founder and Managing Director, FSG Group
Rogier Snijdewind, Head of Responsible Investing, PGGM
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
#AlwaysInnovating: Pharmaceutical Industry Facts & Figures
This compendium of facts and figures aims to provide a snapshot of the contribution of the pharmaceutical industry. Pharmaceutical companies are at the forefront of developing medicines and vaccines that change how we fight and prevent disease and help solve today’s biggest health challenges. In addition to their contribution to healthier societies, pharmaceutical companies also...
Read more
WIPO Standing Committee on Patents: Statement on Technology Transfer
On 16 October 2024 in Geneva, IFPMA delivered a statement at the 36th meeting of WIPO’s Standing Committee on Patents:, on technology transfer.
Read moreWIPO Standing Committee on Patents: Statement on Patents and Health
On 16 October 2024 in Geneva, IFPMA delivered a statement at the 36th meeting of WIPO’s Standing Committee on Patents: Patents and Health.
Read more